Concepedia

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1

Richard A. Rudick, Diane L. Cookfair, Nancy A. Simonian, Richard M. Ransohoff, John R. Richert, Robert M. Herndon, Andres Μ. Salazar, Jill S. Fischer, Carl V. Granger, Donald E. Goodkin,

Journal of Neuroimmunology · 1999 · 97 citations · 22 references

DOI

Concepts

References

22

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

, , +12

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

, , +14

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text

, , +14

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Marc Girard, Pierre Duquette, W. A. Sibley · 1993 · 1.2K citations

, , +10

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Catherine S. Tripp, S F Wolf, Emil R. Unanue · Proceedings of the National Academy of Sciences · 1993 · 781 citations · Full text

, , +17